- Health Secretary Wes Streeting has pledged to prevent people from being priced out of weight-loss jabs, advocating for greater NHS provision.
- This commitment follows concerns over rising costs, particularly for drugs like Mounjaro, which have seen price increases in the private sector.
- Mr Streeting said that healthcare access should be based on need, not ability to pay, aligning with the founding principles of the NHS.
- The NHS’s 10-year plan aims to expand access to these treatments, potentially making them available on the high street or through digital services.
- While Mounjaro's manufacturer, Eli Lilly, initially announced significant price hikes, a discounted deal for UK suppliers is expected to limit the final cost increase for consumers.
IN FULL
